Table 2.
Predictors of progression-free survival and overall survival on multivariate analysis in patients with low-grade gliomasa
| Parameters | PFS | OS | ||||
|---|---|---|---|---|---|---|
| Risk ratio | 95% CI | p-value | Risk ratio | 95% CI | p-value | |
| HLA-E expression | 1.717 | 1.088–2.710 | 0.020 | 1.778 | 1.080–2.926 | 0.024 | 
| Age | 1.065 | 1.023–1.109 | 0.002 | 1.072 | 1.022–1.125 | 0.005 | 
| Sex (male) | 0.909 | 0.452–1.839 | 0.790 | 1.484 | 0.681–3.233 | 0.321 | 
| KPS | 0.899 | 0.862–0.938 | < 0.001 | 0.906 | 0.866–0.947 | < 0.001 | 
| Side (Left) | 0.899 | 0.452–1.788 | 0.761 | 1.317 | 0.608–2.853 | 0.486 | 
PFS Progression-free survival, OS overall survival, LGG low-grade glioma, CI confidence interval, KPS Karnofsky performance score
a Results of Cox regression analysis